ArticleBMC geriatrics2026
Association of MoCA-measured cognitive functions with decision-making capacity in older adults with cognitive impairment.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe rising cognitive impairment prevalence challenge healthcare systems and the independence of older adults. Since the capacity to make decisions about everyday activities and medical treatment is central to maintaining autonomy, we investigated how MoCA-measured cognitive functions are associated with this capacity.
methodsCross-sectional data were collected from 457 older adults with cognitive impairment. Cognitive functions were measured by the Montreal Cognitive Assessment (MoCA) Beijing Version. The Chinese version of the Assessment of Capacity for Everyday Decision-making (ACED) and the MacArthur Competency Assessment Tool for Treatment (MacCAT-T) were used to assess the decision-making capacity for both medication management and treatment from understanding, appreciation, reasoning, and expressing a choice. Multiple linear regression was conducted to analyze the association of MoCA-measured cognitive functions with decision-making capacity for medication management and treatment.
resultsMoCA-measured cognitive domains accounted for 30.1%-67.4% of the variance in decision-making capacities to medication management and treatment in multivariate models. Attention and language abilities consistently emerged as the strongest predictors across all four domains of decision-making capacities for both medication management and treatment. Visuospatial and executive abilities and orientation showed significant effect on understanding and appreciation in both decision contexts. Abstract thinking and delayed recall were non-significant in the models of both decision-making capacities.
conclusionsOur findings identified attention and language abilities as the strongest predictors of decision-making capacity for both medication management and treatment for older adults with cognitive impairment. These results underscore the potential for MoCA-based cognitive assessments to inform evaluations of decision-making autonomy, thereby guiding the provision of person-centered long-term care. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.